Annual Hospitalizations for COVID-19, Influenza, and Respiratory Syncytial Virus, United States, 2023-2024.

ABSTRACT: Projections for the US 2023-24 respiratory virus season indicated a 31% decrease to a 55% increase in hospitalizations for respiratory syncytial virus, influenza, and COVID-19 compared with 2022-23, depending on circulating variants and vaccination uptake. The projections captured the tripledemic peak but missed the multiwave seasonality of COVID-19.

SUBMITTER: Bi K 

PROVIDER: S-EPMC11878295 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature